Dr. Stephen J. Schuster, MD

Dr. Schuster practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Schuster's NPI, 1033147566, was assigned on June 30, 2006. Dr. Schuster graduated from Sidney Kimmel Medical College in 1981. Dr. Schuster holds Pennsylvania license MD027079E.

Dr. Schuster's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Schuster's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Schuster is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Schuster to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schuster practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Schuster's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Schuster is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Schuster's licenses on file in 2 states: Pennsylvania and Florida.

Dmand AI lists breast cancer, chronic leukemia, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Schuster treats.

CMS data shows 977 Medicare services from Dr. Schuster across 7 procedure codes in 2024, for 231 Medicare patients. Medicare paid $43,198 for them.

CMS counts 231 Medicare patients who saw Dr. Schuster in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schuster's median patient age at 74, with 47% women.

In 2024, Dr. Schuster wrote 240 Medicare Part D claims for 68 patients. 69% of them were for generic drugs. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $607,199 in total drug cost. In 2023, CMS named 134 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Schuster for performance year 2024, reported as part of a group. Dr. Schuster accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schuster as offering telehealth.

Dmand AI links 313 papers to Dr. Schuster, published from 2002 to 2025. 2018 was the busiest year, with 22. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse and Immunotherapy, Adoptive. Dr. Schuster has published most often in Blood Adv. Dr. Schuster's most frequent co-authors are Jakub Svoboda, MD, Elise A. Chong, MD and Daniel J. Landsburg, MD.

Dmand AI links Dr. Schuster to 19 clinical trials, 6 of them phase 1 studies. 6 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Lymphoma, Non-Hodgkin and Leukemia, Lymphocytic, Chronic, B-Cell. Abramson Cancer Center at Penn Medicine sponsors the most, 4.

CMS Open Payments shows 368 general payments to Dr. Schuster from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Novartis Pharmaceuticals Corporation paid the most, $82,976. It also lists 35 research payments totaling $36,831 from 2016 to 2025.

Dmand AI lists 5 awards for Dr. Schuster, most recently America's Top Doctors in 2014.

Dr. Schuster graduated from Sidney Kimmel Medical College in 1981.

Dr. Schuster is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.